Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daprodustat in Japanese CKD Anemia
NCT02791763Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2016
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of daprodustat in anemia of chronic kidney disease (CKD-A) (3 arms), sponsored by GSK. Primary endpoint: Mean Hemoglobin During the Primary Efficacy Evaluation Period. Started Jun 2016; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT02791763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02791763.